Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCrunchbase News

Fintech Startups Globally Raise More Money In Far Fewer Deals In Q1 2026

View original at news.crunchbase.com
Crunchbase News - Funding Ma Title: Fintech Startups Globally Raise More Money In Far Fewer Deals In Q1 2026 Date: 2026-04-10 11:00 Source: https://news.crunchbase.com/fintech/global-startup-venture-funding-up-deals-down-q1-2026/ <p>Venture funding to fintech companies is up year over year so far, but concentrated into…
Opening lines of the source · Crunchbase News · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • QED is extremely bullish on the application layer for AI in fintech and stablecoin opportunities

    60% confidence
  • More transformation is moving from the 'co-pilot' phase into the 'OpenClaw' phase, when reasoning agents will start to actually do all the work that was too tedious and slow to be done manually

    60% confidence
  • TTV sees the biggest opportunity in early-stage AI-native companies solving problems in mission-critical workflows while building durable moats

    60% confidence
  • TTV is investing in AI-enabled applications while maintaining patience and focus in deployment of capital, looking for durable, enduring businesses that will withstand the current hype cycle

    60% confidence
  • We may see some fintech IPOs in 2026, but they will largely depend on how potential mega IPOs from SpaceX, OpenAI and Anthropic perform

    60% confidence
  • QED Investors has been investing at a slightly slower pace so far in 2026 than in years past, more due to quirks of deal flow and conviction rather than a decision to slow investing

    60% confidence
  • QED remains bullish on fintech overall for 2026, with larger companies transforming operations with agentic workflows

    60% confidence
  • TTV agrees with Bill Gurley that an AI reset is coming, with many investors having already made money getting in on the ground floor

    60% confidence
  • The geopolitical situation will likely hinder some companies from taking the IPO plunge, although a few companies in QED's portfolios are bubbling

    60% confidence
  • AI agents are now actually able to be effective in many processing tasks, but the stakes in finance are too high for LLMs to conquer financial workflows alone

    60% confidence
  • TTV is focused on investing in the application layer of AI, still in the early days with more widespread prosperity and democratization of enterprise value creation yet to come

    60% confidence
  • An AI reset is coming

    60% confidence
  • TTV Capital is on track to make eight to 10 core investments in Seed or Series A companies in 2026, about the same number as in previous years

    60% confidence
  • Financial services and fintech are unique enough categories where de novo startups and standalone businesses will beat platforms building experimental applications

    60% confidence
  • We'll continue to see accelerated adoption of AI in financial services, first through straightforward applications, then more operationally complex use cases

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com